# Ketamine Effects as Preemptive Analgesia

> **NCT06040060** · PHASE2,PHASE3 · COMPLETED · sponsor: **Universitas Padjadjaran** · enrollment: 40 (actual)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** Ketamine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06040060
- **Lead sponsor:** Universitas Padjadjaran
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-27
- **Primary completion:** 2023-03-03
- **Final completion:** 2023-03-03
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06040060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06040060, "Ketamine Effects as Preemptive Analgesia". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06040060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*